SEC Form 4 · accession 0001055726-17-000031
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Bickerstaff
Director
Period of report
May 12, 2017
Accepted (ET)
May 15, 2017 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | $0.00 | May 12, 2017 | A | 7,669 | A | — | — | Common Stock | 7,669 | 7,669 | D |
| Common Stock OptionF2 | $7.14 | May 12, 2017 | A | 12,500 | A | May 12, 2018 | May 12, 2027 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018.
- F2Options to vest 100% on May 12, 2018.